Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01804088 · ClinicalTrials.gov registry record · NA

FORMAT Clinical Study

A NA study, sponsored by Cook Group Incorporated.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT01804088 is a NA study that has completed, run by Cook Group Incorporated. The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01804088, a NA study, has completed, sponsored by Cook Group Incorporated.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

The FORMAT Clinical Study is a clinical trial to evaluate the safety and effectiveness of the Formula™ 535 Iliac Balloon-Expandable Stent in treatment of symptomatic vascular disease of the iliac arteries.

Interventions

  • DEVICE Formula™ 535 Iliac Balloon-Expandable Stent

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2013-03
Est. Completion 2017-07-17
Phase NA

Sponsor

Cook Group Incorporated

31 total trials

What the Registry Record Tells You About NCT01804088

The ClinicalTrials.gov registry entry for NCT01804088 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Formula™ 535 Iliac Balloon-Expandable Stent is the first listed.

NCT01804088 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01804088 about?

NCT01804088 is a clinical study titled "FORMAT Clinical Study". The FORMAT Clinical Study is a clinical trial to evaluate the safety and effectiveness of the Formula™ 535 Iliac Balloon-Expandable Stent in treatment of symptomatic vascular disease of the iliac arteries.

What is the current status of trial NCT01804088?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2013-03. Estimated completion is 2017-07-17.

What interventions are being tested in trial NCT01804088?

The interventions under investigation include: Formula™ 535 Iliac Balloon-Expandable Stent (DEVICE).

Who is sponsoring clinical trial NCT01804088?

This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.